CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-02 | SMITH IAN F Director | Grant or award | +13,172 | 356,380 | ||
| 2022-12-02 | Marlowe Jennifer CSO, FA & Cardiac | Grant or award · Stock Option (Right to Buy) | +95,110 | 95,110 | ||
| 2022-12-02 | Marlowe Jennifer CSO, FA & Cardiac | Grant or award · Restricted Stock Units | +47,555 | 47,555 | ||
| 2022-12-02 | Howton David T See Remarks | Grant or award · Stock Option (Right to Buy) | +104,410 | 104,410 | ||
| 2022-12-02 | Howton David T See Remarks | Grant or award · Restricted Stock Units | +52,205 | 52,205 | ||
| 2022-12-02 | Herzich Paul Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +57,900 | 57,900 | ||
| 2022-12-02 | Herzich Paul Chief Technology Officer | Grant or award · Restricted Stock Units | +28,955 | 28,955 | ||
| 2022-12-02 | Hanrahan Jessie Chief Regulatory Officer | Grant or award · Stock Option (Right to Buy) | +94,899 | 94,899 | ||
| 2022-12-02 | Hanrahan Jessie Chief Regulatory Officer | Grant or award · Restricted Stock Units | +47,449 | 47,449 | ||
| 2022-12-02 | Cumbo Alexander President and CEO | Grant or award | +584 | 584 | ||
| 2022-12-02 | Cumbo Alexander President and CEO | Grant or award · Stock Option (Right to Buy) | +228,900 | 228,900 | ||
| 2022-12-02 | Cumbo Alexander President and CEO | Grant or award · Restricted Stock Units | +114,449 | 114,449 | ||
| 2022-12-02 | Koppel Adam Director | Grant or award · Director Stock Option (Right to Buy) | +2,666 | 2,666 | ||
| 2022-10-03 | SMITH IAN F Director | Option exercise | +24,312 | 343,208 | ||
| 2022-10-03 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −24,312 | 24,312 | ||
| 2022-07-03 | SMITH IAN F Director | Option exercise | +24,313 | 318,896 | ||
| 2022-07-03 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −24,313 | 48,624 | ||
| 2022-06-07 | Sullivan Lynne Marie Director | Grant or award · Director Stock Option (Right to Buy) | +51,000 | 51,000 | ||
| 2022-06-07 | SMITH IAN F Director | Grant or award · Director Stock Option (Right to Buy) | +51,000 | 51,000 | ||
| 2022-06-07 | Nagendran Sukumar Director | Grant or award · Director Stock Option (Right to Buy) | +51,000 | 51,000 |
Page 19 of 21 · 403 trades